Fortrea Holdings Inc
FTRE17.700USD
-0.210-1.17%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
1.63BMarket Cap
LossP/E TTM
More Details of Fortrea Holdings Inc Company
Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
Fortrea Holdings Inc Info
Ticker SymbolFTRE
Company nameFortrea Holdings Inc
IPO dateJun 16, 2023
CEOThakrala (Anshul)
Number of employees15500
Security typeOrdinary Share
Fiscal year-endJun 16
Address8 Moore Drive
CityDURHAM
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code27709
Phone18774950816
Websitehttps://www.fortrea.com/
Ticker SymbolFTRE
IPO dateJun 16, 2023
CEOThakrala (Anshul)
Company Executives of Fortrea Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+175.40%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+114.60%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+114.60%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+114.62%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
--
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Morais
Mr. Mark Morais
Chief Operating Officer and President - Clinical Services
Chief Operating Officer and President - Clinical Services
--
--
Mr. William J. (Bill) Sharbaugh
Mr. William J. (Bill) Sharbaugh
Director
Director
--
--
Ms. Erin L. Russell
Ms. Erin L. Russell
Independent Director
Independent Director
--
--
Ms. Hima B. Inguva
Ms. Hima B. Inguva
Investor Relations
Investor Relations
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+175.40%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+114.60%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+114.60%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+114.62%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
--
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2021
FY2020
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
North America
344.30M
48.47%
Europe
218.70M
30.79%
Other
147.30M
20.74%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Wed, Nov 19
Updated: Wed, Nov 19
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.71%
The Vanguard Group, Inc.
8.69%
Goldman Sachs & Company, Inc.
8.54%
Corvex Management LP
4.88%
State Street Investment Management (US)
4.41%
Other
59.78%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.71%
The Vanguard Group, Inc.
8.69%
Goldman Sachs & Company, Inc.
8.54%
Corvex Management LP
4.88%
State Street Investment Management (US)
4.41%
Other
59.78%
Shareholder Types
Shareholders
Proportion
Investment Advisor
46.30%
Hedge Fund
22.80%
Investment Advisor/Hedge Fund
18.39%
Research Firm
13.93%
Pension Fund
1.41%
Bank and Trust
1.32%
Individual Investor
0.51%
Family Office
0.31%
Holding Company
0.05%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
861
101.77M
121.97%
--
2025Q3
941
101.78M
123.79%
-128.81K
2025Q2
971
101.91M
125.96%
+8.10M
2025Q1
934
96.29M
123.92%
-15.90M
2024Q4
888
96.88M
127.14%
-3.71M
2024Q3
843
100.39M
126.92%
-3.95M
2024Q2
819
103.77M
114.37%
+7.39M
2024Q1
774
92.63M
104.75%
-1.02M
2023Q4
713
91.56M
111.23%
-6.24M
2023Q3
611
90.56M
44.21%
+51.30M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
12.74M
14.03%
+1.79M
+16.37%
Jun 30, 2025
The Vanguard Group, Inc.
8.51M
9.37%
-1.34M
-13.61%
Jun 30, 2025
Goldman Sachs & Company, Inc.
7.74M
8.53%
+7.70M
+19444.90%
Jun 30, 2025
Corvex Management LP
4.51M
4.97%
+33.63K
+0.75%
Jun 30, 2025
State Street Investment Management (US)
4.43M
4.88%
+1.17M
+35.82%
Jun 30, 2025
Sessa Capital
3.99M
4.4%
-700.00K
-14.91%
Jun 30, 2025
AQR Capital Management, LLC
6.52M
7.18%
+5.42M
+494.84%
Jun 30, 2025
Fidelity Management & Research Company LLC
2.98M
3.28%
-1.07M
-26.50%
Jun 30, 2025
Charles Schwab Investment Management, Inc.
1.79M
1.97%
+837.64K
+87.99%
Jun 30, 2025
DWS Investments UK Limited
1.63M
1.79%
+462.75K
+39.79%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Brandes US Small-Mid Cap Value ETF
1.39%
Invesco S&P Spin-Off ETF
0.97%
Invesco S&P SmallCap Health Care ETF
0.58%
Invesco S&P SmallCap 600 Revenue ETF
0.25%
Invesco S&P SmallCap 600 Pure Value ETF
0.23%
Schwab Fundamental U.S. Small Company ETF
0.17%
iShares S&P Small-Cap 600 Value ETF
0.16%
Humankind US Stock ETF
0.14%
ProShares Ultra Nasdaq Biotechnology
0.14%
State Street SPDR S&P 600 Small Cap Value ETF
0.13%
View more
Brandes US Small-Mid Cap Value ETF
Proportion1.39%
Invesco S&P Spin-Off ETF
Proportion0.97%
Invesco S&P SmallCap Health Care ETF
Proportion0.58%
Invesco S&P SmallCap 600 Revenue ETF
Proportion0.25%
Invesco S&P SmallCap 600 Pure Value ETF
Proportion0.23%
Schwab Fundamental U.S. Small Company ETF
Proportion0.17%
iShares S&P Small-Cap 600 Value ETF
Proportion0.16%
Humankind US Stock ETF
Proportion0.14%
ProShares Ultra Nasdaq Biotechnology
Proportion0.14%
State Street SPDR S&P 600 Small Cap Value ETF
Proportion0.13%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Fortrea Holdings Inc?
The top five shareholders of Fortrea Holdings Inc are:
BlackRock Institutional Trust Company, N.A. holds 12.74M shares, accounting for 14.03% of the total shares.
The Vanguard Group, Inc. holds 8.51M shares, accounting for 9.37% of the total shares.
Goldman Sachs & Company, Inc. holds 7.74M shares, accounting for 8.53% of the total shares.
Corvex Management LP holds 4.51M shares, accounting for 4.97% of the total shares.
State Street Investment Management (US) holds 4.43M shares, accounting for 4.88% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 12.74M shares, accounting for 14.03% of the total shares.
The Vanguard Group, Inc. holds 8.51M shares, accounting for 9.37% of the total shares.
Goldman Sachs & Company, Inc. holds 7.74M shares, accounting for 8.53% of the total shares.
Corvex Management LP holds 4.51M shares, accounting for 4.97% of the total shares.
State Street Investment Management (US) holds 4.43M shares, accounting for 4.88% of the total shares.
What are the top three shareholder types of Fortrea Holdings Inc?
The top three shareholder types of Fortrea Holdings Inc are:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Goldman Sachs & Company, Inc.
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Goldman Sachs & Company, Inc.
How many institutions hold shares of Fortrea Holdings Inc (FTRE)?
As of 2025Q4, 861 institutions hold shares of Fortrea Holdings Inc, with a combined market value of approximately 101.77M, accounting for 121.97% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -1.82%.
What is the biggest source of revenue for Fortrea Holdings Inc?
In FY2025Q2, the -- business generated the highest revenue for Fortrea Holdings Inc, amounting to -- and accounting for --% of total revenue.
